DZ Bank’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $573K | Sell |
966
-1
| -0.1% | -$498 | ﹤0.01% | 791 |
|
|
2025
Q4 | $471K | Sell |
967
-726
| -43% | -$338K | ﹤0.01% | 798 |
|
|
2025
Q3 | $710K | Hold |
1,693
| – | – | ﹤0.01% | 730 |
|
|
2025
Q2 | $486K | Sell |
1,693
-4,566
| -73% | -$1.36M | ﹤0.01% | 748 |
|
|
2025
Q1 | $1.93M | Buy |
6,259
+718
| +13% | +$246K | ﹤0.01% | 587 |
|
|
2024
Q4 | $1.96M | Sell |
5,541
-7,072
| -56% | -$2.6M | ﹤0.01% | 564 |
|
|
2024
Q3 | $4.52M | Sell |
12,613
-6,394
| -34% | -$2.16M | ﹤0.01% | 478 |
|
|
2024
Q2 | $6.05M | Sell |
19,007
-6,116
| -24% | -$1.62M | 0.01% | 427 |
|
|
2024
Q1 | $5.77M | Buy |
25,123
+5,287
| +27% | +$1.19M | 0.01% | 444 |
|
|
2023
Q4 | $4.36M | Sell |
19,836
-17,928
| -47% | -$4.13M | 0.01% | 478 |
|
|
2023
Q3 | $8.53M | Sell |
37,764
-6,775
| -15% | -$1.56M | 0.01% | 372 |
|
|
2023
Q2 | $9.83M | Buy |
44,539
+837
| +2% | +$185K | 0.01% | 352 |
|
|
2023
Q1 | $9.79M | Buy |
43,702
+5,760
| +15% | +$1.42M | 0.02% | 345 |
|
|
2022
Q4 | $10.6M | Sell |
37,942
-20,610
| -35% | -$5.2M | 0.02% | 335 |
|
|
2022
Q3 | $12.3M | Buy |
58,552
+37,390
| +177% | +$8.36M | 0.02% | 277 |
|
|
2022
Q2 | $4.99M | Buy |
21,162
+10,039
| +90% | +$2.04M | 0.01% | 440 |
|
|
2022
Q1 | $2M | Buy |
11,123
+1,939
| +21% | +$369K | ﹤0.01% | 625 |
|
|
2021
Q4 | $1.98M | Buy |
9,184
+2,801
| +44% | +$550K | ﹤0.01% | 641 |
|
|
2021
Q3 | $1.18M | Hold |
6,383
| – | – | ﹤0.01% | 663 |
|
|
2021
Q2 | $1.15M | Hold |
6,383
| – | – | ﹤0.01% | 664 |
|
|
2021
Q1 | $1.07M | Buy |
+6,383
| New | +$1.06M | ﹤0.01% | 632 |
|
|
2020
Q4 | – | Sell |
-1,981
| Closed | -$200K | – | 910 |
|
|
2020
Q3 | $200K | Buy |
+1,981
| New | +$217K | ﹤0.01% | 683 |
|
|
2019
Q4 | – | Sell |
-16,522
| Closed | -$1.32M | – | 798 |
|
|
2019
Q3 | $1.32M | Sell |
16,522
-42,342
| -72% | -$3.41M | ﹤0.01% | 506 |
|
|
2019
Q2 | $4.59M | Sell |
58,864
-267,209
| -82% | -$25M | 0.01% | 382 |
|
|
2019
Q1 | $38.3M | Buy |
326,073
+104,571
| +47% | +$12.2M | 0.12% | 116 |
|
|
2018
Q4 | $23.3M | Buy |
221,502
+25,793
| +13% | +$2.99M | 0.09% | 154 |
|
|
2018
Q3 | $25M | Sell |
195,709
-23,847
| -11% | -$2.95M | 0.09% | 168 |
|
|
2018
Q2 | $24.8M | Sell |
219,556
-8,062
| -4% | -$886K | 0.09% | 176 |
|
|
2018
Q1 | $25.6M | Sell |
227,618
-15,548
| -6% | -$1.98M | 0.1% | 186 |
|
|
2017
Q4 | $36M | Buy |
243,166
+45,193
| +23% | +$5.75M | 0.14% | 150 |
|
|
2017
Q3 | $23.2M | Buy |
197,973
+10,082
| +5% | +$1.29M | 0.1% | 180 |
|
|
2017
Q2 | $24.4M | Buy |
187,891
+45,540
| +32% | +$5.68M | 0.11% | 164 |
|
|
2017
Q1 | $19.3M | Buy |
142,351
+20,152
| +16% | +$3.05M | 0.09% | 184 |
|
|
2016
Q4 | $17.5M | Buy |
+122,199
| New | +$15.6M | 0.08% | 195 |
|
Other funds holding UTHR
ACA
VPM
VCM
DZ Bank's UTHR Position: Q1 2026 in Review
DZ Bank reduced its United Therapeutics (UTHR) stake by 0.1% in Q1 2026, selling an estimated $498 and leaving 966 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #791.
DZ Bank first reported a position in UTHR in Q4 2016 and has held it in 34 quarters since. The position peaked at $38.3M in Q1 2019. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- DZ Bank held 966 shares of United Therapeutics worth $573K as of Q1 2026.
- DZ Bank sold 1 United Therapeutics share in Q1 2026, an estimated $498.
- United Therapeutics made up ﹤0.01% of DZ Bank's portfolio in Q1 2026, its #791 holding.
- DZ Bank first reported a position in United Therapeutics in Q4 2016 and has held it in 34 quarters since.
- DZ Bank's United Therapeutics position peaked at $38.3M in Q1 2019.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.